Clinical trials in Bystra

1 clinical trial in Bystra, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in PolandBadaniaKliniczne.pl

Bystra at a glance

clinical trial

Not yet recruiting0
Paediatric trials0
Research sites0

Quick filters

1 trial in Bystra

Open in trial search

Non-small cell lung cancer

Recruiting

Adjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC

Registered drugNo placebo

Adjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Divarasib
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Warsaw1 824 trials · 33 research sites
Cracow1 228 trials · 15 research sites
Lodz1 026 trials · 18 research sites
Poznan955 trials · 11 research sites
Wroclaw951 trials · 13 research sites
Gdansk869 trials · 11 research sites
Lublin814 trials · 7 research sites
Katowice743 trials · 18 research sites

Back to Poland All countries

Clinical trials in Bystra

1 trial in Bystra

Non-small cell lung cancer

Adjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC

Filter the trials

Other cities in Poland

Prefer not to search? Our Concierge searches the trials for you.

Clinical trials in Bystra

1 trial in Bystra

Non-small cell lung cancer

Adjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC

Other cities in Poland

Related

Prefer not to search? Our Concierge searches the trials for you.